SCHEMBL30833800

SCHEMBL30833800

CN1CCN(c2cnc3ccc(Nc4ncc(Cl)c(Nc5ccccc5CN[SH](=O)=O)n4)cc3n2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP3K7 O43318 4/20 0.53
CCNK O75909 2/20 0.51
CCNA2 P20248 2/20 0.51
CDK2 P24941 2/20 0.51
CCND3 P30281 2/20 0.51
CDK9 P50750 2/20 0.51
CDK6 Q00534 2/20 0.51
EGFR P00533 3/20 0.51
ALK Q9UM73 5/20 0.49
FLT3 P36888 1/20 0.49
MAPK1 P28482 2/20 0.48
MAP2K1 Q02750 2/20 0.48
FGFR1 P11362 1/20 0.48
SRC P12931 1/20 0.48
AXL P30530 1/20 0.48
NEK2 P51955 1/20 0.48
SLC2A1 P11166 1/20 0.48
BRD4 O60885 3/20 0.47
CTSC P53634 1/20 0.46
ROS1 P08922 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30833637 0.97 MAP3K7 (0.53) MAP3K7CCNKCCNA2CDK2CCND3
SCHEMBL30833735 0.88 EGFR (0.52) MAP3K7EGFRFLT3FGFR1SRC
SCHEMBL30833720 0.86 AXL (0.52) MAP3K7CCNKCCNA2CDK2CCND3
SCHEMBL29190531 0.84 ALK (0.65) MAP3K7CCNKCCNA2CDK2CCND3
SCHEMBL30833713 0.83 AXL (0.52) MAP3K7CCNKCCNA2CDK2CCND3
SCHEMBL29190637 0.81 ALK (0.65) MAP3K7CCNKCCNA2CDK2CCND3
SCHEMBL16966032 0.78 INSR (0.53) MAP3K7CCNKCCNA2CDK2CCND3
SCHEMBL26611961 0.78 EGFR (0.72) MAP3K7EGFRALKFLT3FGFR1
SCHEMBL30833783 0.78 SYK (0.47) MAP3K7CCNKCCNA2CDK2CCND3
SCHEMBL16966205 0.77 MET (0.47) MAP3K7CCNKCCNA2CDK2CCND3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113896744-B Selective EGFR inhibitor 成都先导药物开发股份有限公司 2024-04-16 CN disclosed